首页 > 最新文献

BMC Endocrine Disorders最新文献

英文 中文
The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-11 DOI: 10.1186/s12902-025-01891-7
Wanqian Liu, Xiaozhong Li, Ling Chen, Xiao Luo

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, also considered a metabolic syndrome, and is associated with poor prognosis. eGDR (estimated glucose disposal rate) is a new biomarker to assessment insulin resistance (IR). The association between eGDR and MASLD and liver fibrosis is currently unclear.

Objective: The aim of this cross-sectional study is to appraise the association between eGDR and MASLD and liver fibrosis.

Methods: This study have enrolled 3,100 participants from the 2017-2018 National Health and Nutrition Examination Surveys (NHANES). Binary logistic regression analysis was used to assess the association between eGDR and MASLD and liver fibrosis. Receiver operating characteristic (ROC) was applied to estimate the ability of eGDR to identify MASLD.

Results: The mean age of the subjects was 54.59 (17.29) years, and 49.26% were female. The prevalence of MASLD and liver fibrosis was 62.19% and 11.15%, respectively. In the fully adjusted models, there were negative associations of eGDR with the controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with βs of -15.18 and - 0.74 (all p < 0.01), respectively. There were negative associations of eGDR with MASLD and liver fibrosis, with odds ratios (ORs) and 95% confidence intervals of 0.53 (95% CI: 0.48-0.74) and 0.40 (95% CI: 0.28-0.57) (all p < 0.01). The area under the curve (AUC) of the eGDR for identifying MASLD and liver fibrosis is 0.74 and 0.75, respectively.

Conclusion: The study findings suggest a significant association between eGDR and MASLD as well as liver fibrosis. eGDR may serve as a biomarker for identifying MASLD.

{"title":"The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults.","authors":"Wanqian Liu, Xiaozhong Li, Ling Chen, Xiao Luo","doi":"10.1186/s12902-025-01891-7","DOIUrl":"10.1186/s12902-025-01891-7","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, also considered a metabolic syndrome, and is associated with poor prognosis. eGDR (estimated glucose disposal rate) is a new biomarker to assessment insulin resistance (IR). The association between eGDR and MASLD and liver fibrosis is currently unclear.</p><p><strong>Objective: </strong>The aim of this cross-sectional study is to appraise the association between eGDR and MASLD and liver fibrosis.</p><p><strong>Methods: </strong>This study have enrolled 3,100 participants from the 2017-2018 National Health and Nutrition Examination Surveys (NHANES). Binary logistic regression analysis was used to assess the association between eGDR and MASLD and liver fibrosis. Receiver operating characteristic (ROC) was applied to estimate the ability of eGDR to identify MASLD.</p><p><strong>Results: </strong>The mean age of the subjects was 54.59 (17.29) years, and 49.26% were female. The prevalence of MASLD and liver fibrosis was 62.19% and 11.15%, respectively. In the fully adjusted models, there were negative associations of eGDR with the controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with βs of -15.18 and - 0.74 (all p < 0.01), respectively. There were negative associations of eGDR with MASLD and liver fibrosis, with odds ratios (ORs) and 95% confidence intervals of 0.53 (95% CI: 0.48-0.74) and 0.40 (95% CI: 0.28-0.57) (all p < 0.01). The area under the curve (AUC) of the eGDR for identifying MASLD and liver fibrosis is 0.74 and 0.75, respectively.</p><p><strong>Conclusion: </strong>The study findings suggest a significant association between eGDR and MASLD as well as liver fibrosis. eGDR may serve as a biomarker for identifying MASLD.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"67"},"PeriodicalIF":2.8,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11895387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143596110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to low carbohydrate diet is inversely associated with metabolic syndrome: evidence from MASHAD study.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-10 DOI: 10.1186/s12902-025-01878-4
Sanaz Soltani, Glareh Koochakpoor, Melika Gharizadeh, Simin Rashidian Yazd, Maryam Mohammadi-Bajgiran, Alireza Ghajary, Ali Zeyqami, Gordon A Ferns, Majid Ghayour-Mobarhan

Background: We studied the link between adherence to a low carbohydrate diet (LCD) and metabolic syndrome (MetS) and its components in Iranian population.

Methods: In this cross-sectional study, a validated 65-item food frequency questionnaire was used to collect dietary intakes from 3847 Iranian adults aged 35 to 65 years. These intakes were then used to calculate the LCD scores. The definition of metabolic syndrome followed the guidelines provided by the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI). To explore the association between LCD and MetS, multivariate logistic regression was employed in three models.

Results: After accounting for potential confounding factors, individuals in the highest quartile of LCD score demonstrated a lower probability of having MetS compared to those in the lowest quartile (OR: 0.70; 95% CI: 0.56-0.88). When the analyses were performed for components of MetS, we found that compared to individuals in the bottom quartile, those in the top quartile of LCD score had a lower odds of enlarged waist circumference (OR: 0.62; 95% CI: 0.49-0.79), low serum HDL cholesterol (OR: 0.75; 95% CI: 0.62-0.92) and elevated blood pressure (OR: 0.71; 95% CI: 0.57-0.88). Regarding other components of MetS, no significant association was seen between LCD score and high serum triacylglycerol concentrations and abnormal glucose homeostasis.

Conclusions: We found that adherence to a LCD was inversely related to MetS and its components including low serum HDL-C, elevated blood pressure, and enlarged waist circumference.

Clinical trial number: Not applicable.

背景:我们研究了伊朗人坚持低碳水化合物饮食(LCD)与代谢综合征(MetS)及其组成部分之间的联系:在这项横断面研究中,我们使用经过验证的 65 项食物频率调查问卷,收集了 3847 名 35 至 65 岁伊朗成年人的饮食摄入量。这些摄入量随后被用来计算 LCD 分数。代谢综合征的定义遵循美国心脏协会/国家心肺血液研究所(AHA/NHLBI)提供的指南。为了探讨LCD与代谢综合征之间的关系,我们在三个模型中采用了多变量逻辑回归法:在考虑了潜在的混杂因素后,LCD得分最高四分位数的人与最低四分位数的人相比,患 MetS 的概率较低(OR:0.70;95% CI:0.56-0.88)。在对 MetS 的组成因素进行分析时,我们发现与处于最低四分位数的人相比,LCD 评分处于最高四分位数的人出现腰围增大(OR:0.62;95% CI:0.49-0.79)、血清高密度脂蛋白胆固醇偏低(OR:0.75;95% CI:0.62-0.92)和血压升高(OR:0.71;95% CI:0.57-0.88)的几率较低。至于 MetS 的其他组成部分,LCD 评分与高血清三酰甘油浓度和葡萄糖稳态异常之间没有明显关联:结论:我们发现,坚持LCD与MetS及其组成部分(包括低血清高密度脂蛋白胆固醇、血压升高和腰围增大)成反比:临床试验编号:不适用。
{"title":"Adherence to low carbohydrate diet is inversely associated with metabolic syndrome: evidence from MASHAD study.","authors":"Sanaz Soltani, Glareh Koochakpoor, Melika Gharizadeh, Simin Rashidian Yazd, Maryam Mohammadi-Bajgiran, Alireza Ghajary, Ali Zeyqami, Gordon A Ferns, Majid Ghayour-Mobarhan","doi":"10.1186/s12902-025-01878-4","DOIUrl":"10.1186/s12902-025-01878-4","url":null,"abstract":"<p><strong>Background: </strong>We studied the link between adherence to a low carbohydrate diet (LCD) and metabolic syndrome (MetS) and its components in Iranian population.</p><p><strong>Methods: </strong>In this cross-sectional study, a validated 65-item food frequency questionnaire was used to collect dietary intakes from 3847 Iranian adults aged 35 to 65 years. These intakes were then used to calculate the LCD scores. The definition of metabolic syndrome followed the guidelines provided by the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI). To explore the association between LCD and MetS, multivariate logistic regression was employed in three models.</p><p><strong>Results: </strong>After accounting for potential confounding factors, individuals in the highest quartile of LCD score demonstrated a lower probability of having MetS compared to those in the lowest quartile (OR: 0.70; 95% CI: 0.56-0.88). When the analyses were performed for components of MetS, we found that compared to individuals in the bottom quartile, those in the top quartile of LCD score had a lower odds of enlarged waist circumference (OR: 0.62; 95% CI: 0.49-0.79), low serum HDL cholesterol (OR: 0.75; 95% CI: 0.62-0.92) and elevated blood pressure (OR: 0.71; 95% CI: 0.57-0.88). Regarding other components of MetS, no significant association was seen between LCD score and high serum triacylglycerol concentrations and abnormal glucose homeostasis.</p><p><strong>Conclusions: </strong>We found that adherence to a LCD was inversely related to MetS and its components including low serum HDL-C, elevated blood pressure, and enlarged waist circumference.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"62"},"PeriodicalIF":2.8,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-10 DOI: 10.1186/s12902-025-01879-3
Angelo Di Vincenzo, Marnie Granzotto, Marika Crescenzi, Paola Fioretto, Roberto Vettor, Marco Rossato

Background: the metabolic effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i), such as lipolysis and ectopic fat reduction, seem related to the synthesis of fibroblast growth factor-21 (FGF-21), and FGF-21 analogs are now under investigation for the treatment of obesity complications such as metabolic dysfunction-associated steatotic liver disease. However, FGF-21 levels are paradoxically higher in obesity, indicating a hormone-resistant state that may hinder the benefits of SGLT2i.

Methods: To define if a different energy status influences the response to SGLT2i, we evaluated the effects of dapagliflozin administration on nine-week-old C57BL/6J wild-type and B6.V-LEP ob/ob mice as a model of genetic obesity. Blood glucose, body weight and food intake were evaluated, and the FGF-21 expression was determined in subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and brown adipose tissue (BAT). In the liver, FGF-21 gene expression, protein concentration and triglyceride content were evaluated.

Results: glucose plasma levels and body weight were higher in ob/ob than in lean mice. After four weeks of treatment, dapagliflozin reduced blood glucose levels and body weight in both animal models, but weight loss was more significant in lean mice. The baseline expression of FGF-21 was higher in both SAT, VAT and the liver of ob/ob mice, whereas it was almost undetectable in BAT in both animal groups. After the treatment period, dapagliflozin was shown to increase FGF-21 expression in VAT only in lean animals, while the expression was unaffected in ob/ob mice. Similar effects were observed in the liver analyses, along with no variation in triglyceride content.

Conclusions: SGLT2i administration results in less pronounced metabolic effects in ob/ob mice than in lean mice. This data suggests a less sensitive response in obesity, probably due to a chronic stimulation leading to abnormalities of the SGLT2i-FGF-21 axis which should be considered in managing patients affected by genetic obesity.

{"title":"The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice.","authors":"Angelo Di Vincenzo, Marnie Granzotto, Marika Crescenzi, Paola Fioretto, Roberto Vettor, Marco Rossato","doi":"10.1186/s12902-025-01879-3","DOIUrl":"10.1186/s12902-025-01879-3","url":null,"abstract":"<p><strong>Background: </strong>the metabolic effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i), such as lipolysis and ectopic fat reduction, seem related to the synthesis of fibroblast growth factor-21 (FGF-21), and FGF-21 analogs are now under investigation for the treatment of obesity complications such as metabolic dysfunction-associated steatotic liver disease. However, FGF-21 levels are paradoxically higher in obesity, indicating a hormone-resistant state that may hinder the benefits of SGLT2i.</p><p><strong>Methods: </strong>To define if a different energy status influences the response to SGLT2i, we evaluated the effects of dapagliflozin administration on nine-week-old C57BL/6J wild-type and B6.V-LEP ob/ob mice as a model of genetic obesity. Blood glucose, body weight and food intake were evaluated, and the FGF-21 expression was determined in subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and brown adipose tissue (BAT). In the liver, FGF-21 gene expression, protein concentration and triglyceride content were evaluated.</p><p><strong>Results: </strong>glucose plasma levels and body weight were higher in ob/ob than in lean mice. After four weeks of treatment, dapagliflozin reduced blood glucose levels and body weight in both animal models, but weight loss was more significant in lean mice. The baseline expression of FGF-21 was higher in both SAT, VAT and the liver of ob/ob mice, whereas it was almost undetectable in BAT in both animal groups. After the treatment period, dapagliflozin was shown to increase FGF-21 expression in VAT only in lean animals, while the expression was unaffected in ob/ob mice. Similar effects were observed in the liver analyses, along with no variation in triglyceride content.</p><p><strong>Conclusions: </strong>SGLT2i administration results in less pronounced metabolic effects in ob/ob mice than in lean mice. This data suggests a less sensitive response in obesity, probably due to a chronic stimulation leading to abnormalities of the SGLT2i-FGF-21 axis which should be considered in managing patients affected by genetic obesity.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"63"},"PeriodicalIF":2.8,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroidectomy, especially total thyroidectomy, adversely affects erectile function in men.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-10 DOI: 10.1186/s12902-025-01886-4
Yushu Huang, Dan Guo, Daixing Hu, Yaru Yang, Qin Deng

Objectives: To evaluate the frequency of erectile dysfunction in male patients who undergo thyroidectomy using the International Index of Erectile Function (IIEF-5), and explore possible risk factors.

Methods: 163 male patients who undergo partial, unilateral or bilateral thyroidectomy between December 2021 and September 2022 were retrospectively studied. The IIEF-5 questionnaires were completed 6 and 12 months after surgery, and patients who reported erectile dysfunction (ED) before surgery were not included. Sociodemographic factors (age, education status, and employment status) and health behavior (smoking and alcohol consumption) were also recorded. The above factors and clinical data were included for statistical analysis.

Results: Fifty-five patients underwent total thyroidectomy (TT), 67 underwent hemithyroidectomy (HT), and 41 underwent partial thyroidectomy (PT). Six months after surgery, 33 patients (60%) in the TT group, 38 (56.7%) patients in the HT group, and 11(26.8%) patients in the PT group reported ED. The lowest scores were observed in the TT group (TT: 19.22 ± 3.895, HT: 20.67 ± 2.836, PT: 21.98 ± 1.651, P < 0.05). At the 12-month postoperative visit, the mean IIEF-5 scores were better in the HT and PT groups and worse in the TT group (TT: 18.36 ± 4.335, HT: 21.40 ± 2.692, PT: 22.54 ± 1.206, P < 0.05). Binary logistic regression analysis revealed that age and extent of resection significantly affected the onset of postoperative ED.

Conclusions: Thyroidectomy, especially the total thyroidectomy, adversely affects erectile function. In addition to the operative procedure, age was also found to be significantly associated with postoperative ED.

{"title":"Thyroidectomy, especially total thyroidectomy, adversely affects erectile function in men.","authors":"Yushu Huang, Dan Guo, Daixing Hu, Yaru Yang, Qin Deng","doi":"10.1186/s12902-025-01886-4","DOIUrl":"10.1186/s12902-025-01886-4","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the frequency of erectile dysfunction in male patients who undergo thyroidectomy using the International Index of Erectile Function (IIEF-5), and explore possible risk factors.</p><p><strong>Methods: </strong>163 male patients who undergo partial, unilateral or bilateral thyroidectomy between December 2021 and September 2022 were retrospectively studied. The IIEF-5 questionnaires were completed 6 and 12 months after surgery, and patients who reported erectile dysfunction (ED) before surgery were not included. Sociodemographic factors (age, education status, and employment status) and health behavior (smoking and alcohol consumption) were also recorded. The above factors and clinical data were included for statistical analysis.</p><p><strong>Results: </strong>Fifty-five patients underwent total thyroidectomy (TT), 67 underwent hemithyroidectomy (HT), and 41 underwent partial thyroidectomy (PT). Six months after surgery, 33 patients (60%) in the TT group, 38 (56.7%) patients in the HT group, and 11(26.8%) patients in the PT group reported ED. The lowest scores were observed in the TT group (TT: 19.22 ± 3.895, HT: 20.67 ± 2.836, PT: 21.98 ± 1.651, P < 0.05). At the 12-month postoperative visit, the mean IIEF-5 scores were better in the HT and PT groups and worse in the TT group (TT: 18.36 ± 4.335, HT: 21.40 ± 2.692, PT: 22.54 ± 1.206, P < 0.05). Binary logistic regression analysis revealed that age and extent of resection significantly affected the onset of postoperative ED.</p><p><strong>Conclusions: </strong>Thyroidectomy, especially the total thyroidectomy, adversely affects erectile function. In addition to the operative procedure, age was also found to be significantly associated with postoperative ED.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"61"},"PeriodicalIF":2.8,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between serum chloride and prevalence of metabolic syndrome in the general U.S. adult population: evidence from NHANES 2011-2018.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-10 DOI: 10.1186/s12902-025-01847-x
Lun Zhang, Hongpeng Liu, Xiaoling Lv, Jianmei Zhou, Rongfang Zhou, Wenming Xing, Qing Wu

Aim: Numerous studies have revealed the decisive role of serum chloride in the outcome of specific patients. However, the potential role of serum chloride in general populations has been rarely investigated. This study aims to assess the association of serum chloride with MetS risk in the general population.

Methods: A total of 13,290 adult participants were obtained from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018. The association between serum chloride and MetS was investigated using weighted logistic regression analyses. The weighted restricted cubic spline (RCS) was constructed based on the fully adjusted model to explore its dose-response relationship. Further stratified analyses were also conducted. All data and analyses were conducted using the "Survey" package in R software (Version 4.4.1).

Results: The average age of this population was 48.20 ± 0.35, the average BMI was 29.42 ± 0.12 kg/m2, included 48.54% males, and the weighted prevalence of MetS was 37.83%. After adjusting full covariates, serum chloride was negatively associated with MetS risk in overweight or obese participants who did not smoke or heavy drink. Meanwhile, serum chloride was significantly inversely correlated with the raised fast glucose (FG), total cholesterol (TG) and blood pressure (BP), and positively related with the reduced high density lipoprotein cholesterol (HDL-C). Consistent results were observed in the RCS analysis.

Conclusion: This study suggested a potential inverse relationship between serum chloride levels and MetS risk. Understanding this link may offer fresh perspectives on preventing and treating MetS, presenting new therapeutic targets and strategies for public health improvement.

{"title":"Association between serum chloride and prevalence of metabolic syndrome in the general U.S. adult population: evidence from NHANES 2011-2018.","authors":"Lun Zhang, Hongpeng Liu, Xiaoling Lv, Jianmei Zhou, Rongfang Zhou, Wenming Xing, Qing Wu","doi":"10.1186/s12902-025-01847-x","DOIUrl":"10.1186/s12902-025-01847-x","url":null,"abstract":"<p><strong>Aim: </strong>Numerous studies have revealed the decisive role of serum chloride in the outcome of specific patients. However, the potential role of serum chloride in general populations has been rarely investigated. This study aims to assess the association of serum chloride with MetS risk in the general population.</p><p><strong>Methods: </strong>A total of 13,290 adult participants were obtained from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018. The association between serum chloride and MetS was investigated using weighted logistic regression analyses. The weighted restricted cubic spline (RCS) was constructed based on the fully adjusted model to explore its dose-response relationship. Further stratified analyses were also conducted. All data and analyses were conducted using the \"Survey\" package in R software (Version 4.4.1).</p><p><strong>Results: </strong>The average age of this population was 48.20 ± 0.35, the average BMI was 29.42 ± 0.12 kg/m<sup>2</sup>, included 48.54% males, and the weighted prevalence of MetS was 37.83%. After adjusting full covariates, serum chloride was negatively associated with MetS risk in overweight or obese participants who did not smoke or heavy drink. Meanwhile, serum chloride was significantly inversely correlated with the raised fast glucose (FG), total cholesterol (TG) and blood pressure (BP), and positively related with the reduced high density lipoprotein cholesterol (HDL-C). Consistent results were observed in the RCS analysis.</p><p><strong>Conclusion: </strong>This study suggested a potential inverse relationship between serum chloride levels and MetS risk. Understanding this link may offer fresh perspectives on preventing and treating MetS, presenting new therapeutic targets and strategies for public health improvement.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"64"},"PeriodicalIF":2.8,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pheochromocytoma in a patient with heterotaxy syndrome: a case report.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-10 DOI: 10.1186/s12902-024-01829-5
Farid Farahani Rad, Fatemeh Esfahanian, Parandoosh Hashemizadeh, Ehsan Mehrtabar

Background: Heterotaxy syndrome is a rare congenital condition characterized by abnormal arrangement of thoracoabdominal organs, often associated with complex cardiac and splenic anomalies. Pheochromocytoma is a rare neuroendocrine tumor that overproduces catecholamines, leading to various complications. The co-occurrence of heterotaxy syndrome and pheochromocytoma has not been previously reported. This case report presents a unique finding of pheochromocytoma in a patient with heterotaxy syndrome and a functioning ectopic spleen, offering novel clinical insights.

Case presentation: A 19-year-old male with congenital heart disease was incidentally found to have a right adrenal mass during abdominal ultrasonography which followed abnormal lab results. Computed tomography (CT) scans confirmed abnormal organ positioning consistent with heterotaxy syndrome, including a midline liver, right-sided colon, and the absence of a spleen in its typical location. Subsequent scintigraphy with Technetium-99 m denatured red blood cells revealed a functioning ectopic spleen in the left subdiaphragmatic space. The right adrenal mass was confirmed to be pheochromocytoma based on elevated urinary catecholamine levels. Despite recommendations for surgery, the patient chose medical management with alpha-blockers and remained stable over a one-year follow-up with no significant events.

Conclusions: This case is notable concurrency of pheochromocytoma and heterotaxy and for the rare occurrence of a functioning ectopic spleen in a patient with heterotaxy syndrome, a condition where splenic anomalies typically manifest as asplenia or polysplenia. The importance of extensive imaging, particularly Tc-99 m labeled denatured erythrocyte scintigraphy imaging, is emphasized, as routine imaging like CT scans may fail to detect ectopic organs. Additionally, the concurrent presence of pheochromocytoma (PCC) and heterotaxy syndrome, although rare, raises intriguing questions about their potential link. While this case does not explore the association in detail, chronic hypoxia caused by congenital cardiovascular anomalies in heterotaxy syndrome could activate hypoxia-inducible factors (HIFs), which may promote tumorigenesis, including the development of PCC. Future studies are warranted to explore these mechanisms further and clarify the pathophysiological connection between heterotaxy syndrome, hypoxia, and PCC.

{"title":"Pheochromocytoma in a patient with heterotaxy syndrome: a case report.","authors":"Farid Farahani Rad, Fatemeh Esfahanian, Parandoosh Hashemizadeh, Ehsan Mehrtabar","doi":"10.1186/s12902-024-01829-5","DOIUrl":"10.1186/s12902-024-01829-5","url":null,"abstract":"<p><strong>Background: </strong>Heterotaxy syndrome is a rare congenital condition characterized by abnormal arrangement of thoracoabdominal organs, often associated with complex cardiac and splenic anomalies. Pheochromocytoma is a rare neuroendocrine tumor that overproduces catecholamines, leading to various complications. The co-occurrence of heterotaxy syndrome and pheochromocytoma has not been previously reported. This case report presents a unique finding of pheochromocytoma in a patient with heterotaxy syndrome and a functioning ectopic spleen, offering novel clinical insights.</p><p><strong>Case presentation: </strong>A 19-year-old male with congenital heart disease was incidentally found to have a right adrenal mass during abdominal ultrasonography which followed abnormal lab results. Computed tomography (CT) scans confirmed abnormal organ positioning consistent with heterotaxy syndrome, including a midline liver, right-sided colon, and the absence of a spleen in its typical location. Subsequent scintigraphy with Technetium-99 m denatured red blood cells revealed a functioning ectopic spleen in the left subdiaphragmatic space. The right adrenal mass was confirmed to be pheochromocytoma based on elevated urinary catecholamine levels. Despite recommendations for surgery, the patient chose medical management with alpha-blockers and remained stable over a one-year follow-up with no significant events.</p><p><strong>Conclusions: </strong>This case is notable concurrency of pheochromocytoma and heterotaxy and for the rare occurrence of a functioning ectopic spleen in a patient with heterotaxy syndrome, a condition where splenic anomalies typically manifest as asplenia or polysplenia. The importance of extensive imaging, particularly Tc-99 m labeled denatured erythrocyte scintigraphy imaging, is emphasized, as routine imaging like CT scans may fail to detect ectopic organs. Additionally, the concurrent presence of pheochromocytoma (PCC) and heterotaxy syndrome, although rare, raises intriguing questions about their potential link. While this case does not explore the association in detail, chronic hypoxia caused by congenital cardiovascular anomalies in heterotaxy syndrome could activate hypoxia-inducible factors (HIFs), which may promote tumorigenesis, including the development of PCC. Future studies are warranted to explore these mechanisms further and clarify the pathophysiological connection between heterotaxy syndrome, hypoxia, and PCC.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"65"},"PeriodicalIF":2.8,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143596108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between waist-to-hip ratio and testosterone in Chinese men with young-onset type 2 diabetes: a cross-sectional study.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-06 DOI: 10.1186/s12902-025-01832-4
Yanan Luo, Hongya Shao, Qiuping Zhang, Fupeng Liu, Mei Zhang, Yanhong Zhang, Yaru Wang, Hui Pan, Bo Ban, Yanying Li

Background: Low testosterone levels is associated with higher cardiovascular risk in men with diabetes. However, there are few studies on testosterone levels and the factors affecting them in patients with young-onset diabetes (YOD). The objective of this study was to investigate the correlation between waist-to-hip ratio (WHR) and testosterone levels in men diagnosed with YOD.

Research design and methods: This cross-sectional study involved 547 male patients with type 2 diabetes mellitus (T2DM) from the Endocrinology Department of the Affiliated Hospital of Jining Medical University. The participants were divided into two groups: a young-onset diabetes (YOD) group and a late-onset diabetes (LOD) group. Anthropometric measurements, including height, weight, waist circumference, and hip circumference, were recorded. Additionally, fasting blood samples were collected to assess various parameters, such as sex hormone levels and lipid profiles. The association between WHR and testosterone levels was analyzed by univariate linear regression and multivariable linear regression analysis.

Results: Five hundred forty-seven patients with type 2 diabetes and aged 50.3 ± 12.1 years were enrolled in the study. One hundred ninety-three patients were assigned to the YOD group based on a diagnosis age of 40 years or younger, while the remaining 354 patients were assigned to the LOD group. The testosterone was significantly lower in the YOD group compare to the LOD group (P = 0.049), and the WHR had an independent effect on testosterone in men with the YOD group (β=-4.67, P = 0.0251), but there was no evidence of such an association in the LOD group (β =-1.13, P = 0.4608).

Conclusions: According to our results, male patients with YOD exhibited lower testosterone levels compared to those with LOD. Furthermore, their testosterone levels were significantly negatively correlated with WHR. These findings indicate that it is more necessary to screen for testosterone in obese patients with YOD and that improving obesity, especially abdominal obesity, may help to interrupt the vicious cycle of low testosterone-obesity-insulin resistance-hyperglycemia-low testosterone.

{"title":"Association between waist-to-hip ratio and testosterone in Chinese men with young-onset type 2 diabetes: a cross-sectional study.","authors":"Yanan Luo, Hongya Shao, Qiuping Zhang, Fupeng Liu, Mei Zhang, Yanhong Zhang, Yaru Wang, Hui Pan, Bo Ban, Yanying Li","doi":"10.1186/s12902-025-01832-4","DOIUrl":"10.1186/s12902-025-01832-4","url":null,"abstract":"<p><strong>Background: </strong>Low testosterone levels is associated with higher cardiovascular risk in men with diabetes. However, there are few studies on testosterone levels and the factors affecting them in patients with young-onset diabetes (YOD). The objective of this study was to investigate the correlation between waist-to-hip ratio (WHR) and testosterone levels in men diagnosed with YOD.</p><p><strong>Research design and methods: </strong>This cross-sectional study involved 547 male patients with type 2 diabetes mellitus (T2DM) from the Endocrinology Department of the Affiliated Hospital of Jining Medical University. The participants were divided into two groups: a young-onset diabetes (YOD) group and a late-onset diabetes (LOD) group. Anthropometric measurements, including height, weight, waist circumference, and hip circumference, were recorded. Additionally, fasting blood samples were collected to assess various parameters, such as sex hormone levels and lipid profiles. The association between WHR and testosterone levels was analyzed by univariate linear regression and multivariable linear regression analysis.</p><p><strong>Results: </strong>Five hundred forty-seven patients with type 2 diabetes and aged 50.3 ± 12.1 years were enrolled in the study. One hundred ninety-three patients were assigned to the YOD group based on a diagnosis age of 40 years or younger, while the remaining 354 patients were assigned to the LOD group. The testosterone was significantly lower in the YOD group compare to the LOD group (P = 0.049), and the WHR had an independent effect on testosterone in men with the YOD group (β=-4.67, P = 0.0251), but there was no evidence of such an association in the LOD group (β =-1.13, P = 0.4608).</p><p><strong>Conclusions: </strong>According to our results, male patients with YOD exhibited lower testosterone levels compared to those with LOD. Furthermore, their testosterone levels were significantly negatively correlated with WHR. These findings indicate that it is more necessary to screen for testosterone in obese patients with YOD and that improving obesity, especially abdominal obesity, may help to interrupt the vicious cycle of low testosterone-obesity-insulin resistance-hyperglycemia-low testosterone.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"60"},"PeriodicalIF":2.8,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143572029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-islet cell tumor hypoglycemia (NICTH) associated with sarcoma, case report.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-05 DOI: 10.1186/s12902-025-01885-5
Atefeh Jannatalipour, Nekoo Panahi, Mahnaz Pejman Sani, Omid Ghaemi, Maryam Kheirandish, Neda Alipour, Azadeh Zarinkolah, Mostafa Jawhari, Bahman Rasuli, Mohammad Reza Mohajeri-Tehrani, Hamid Reza Aghaei Meybodi, Akbar Soltani

Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome caused by the secretion of high molecular weight insulin-like growth factor II (IGF-II) from tumors, particularly those of mesenchymal and epithelial origin. This case report describes a 71-year-old male with pelvic sarcoma who presented with severe hypoglycemia, with blood glucose levels dropping below 40 mg/dL and exhibiting neuroglycopenic symptoms. The diagnosis of NICTH was confirmed through biochemical analysis showing hypoinsulinemic hypoglycemia alongside low C-peptide and IGF-1 levels. Initial management with dextrose infusions and glucocorticoids proved ineffective until recombinant human growth hormone (rhGH) therapy was initiated, resulting in a decreased requirement for dextrose. Following angioembolization of the tumor, the patient's blood glucose levels stabilized sufficiently to allow for the complete cessation of dextrose administration. This case highlights the critical role of rhGH in reducing dextrose dependency and the effectiveness of angioembolization in managing NICTH when surgical options are limited.

{"title":"Non-islet cell tumor hypoglycemia (NICTH) associated with sarcoma, case report.","authors":"Atefeh Jannatalipour, Nekoo Panahi, Mahnaz Pejman Sani, Omid Ghaemi, Maryam Kheirandish, Neda Alipour, Azadeh Zarinkolah, Mostafa Jawhari, Bahman Rasuli, Mohammad Reza Mohajeri-Tehrani, Hamid Reza Aghaei Meybodi, Akbar Soltani","doi":"10.1186/s12902-025-01885-5","DOIUrl":"10.1186/s12902-025-01885-5","url":null,"abstract":"<p><p>Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome caused by the secretion of high molecular weight insulin-like growth factor II (IGF-II) from tumors, particularly those of mesenchymal and epithelial origin. This case report describes a 71-year-old male with pelvic sarcoma who presented with severe hypoglycemia, with blood glucose levels dropping below 40 mg/dL and exhibiting neuroglycopenic symptoms. The diagnosis of NICTH was confirmed through biochemical analysis showing hypoinsulinemic hypoglycemia alongside low C-peptide and IGF-1 levels. Initial management with dextrose infusions and glucocorticoids proved ineffective until recombinant human growth hormone (rhGH) therapy was initiated, resulting in a decreased requirement for dextrose. Following angioembolization of the tumor, the patient's blood glucose levels stabilized sufficiently to allow for the complete cessation of dextrose administration. This case highlights the critical role of rhGH in reducing dextrose dependency and the effectiveness of angioembolization in managing NICTH when surgical options are limited.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"59"},"PeriodicalIF":2.8,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143566140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of anthropometric parameters in predicting prediabetes among adolescents in Eastern Sudan: a community-based cross-sectional study.
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-03 DOI: 10.1186/s12902-025-01890-8
Ola A El-Gendy, Walaa M Alsafi, Khadijah A Al-Shafei, Ahmed A Hassan, Ishag Adam

Introduction: The global increase of prediabetes and diabetes in adolescents raises the issue of early prediction of this metabolic disorder via anthropometric parameters, especially in limited resources settings such as Sudan. However, the reliability of these anthropometric predictors is inconclusive. This study aimed to examine the association between anthropometric measures, including body mass index (BMI), hip circumference (HC), waist circumference (WC), waist-to-hip ratio (WHR), body roundness index (BRI), and a body shape index (ABSI), and prediabetes in adolescents in eastern Sudan.

Methods: This community-based cross-sectional study was conducted among adolescents in Gadarif City, Eastern Sudan. A questionnaire was used to collect sociodemographic information. Anthropometric and glycated hemoglobin (HbA1c) were performed following the standard procedures. The Receiver Operating Characteristic (ROC) curve was generated. Multivariate binary regression analysis was performed.

Results: Among the 401 adolescents, 186 (46.4%) were female, and 215 (53.6%) were male. The median (IQR) age was 14.1 (12.1-16.3) years. There was no correlation between BMI, WC, HC, WHR, BRI, ABSI, and HbA1c levels. Ninety-five (23.7%) adolescents were identified with prediabetes and 10 (2.5%) with diabetes. In univariate analysis, BRI (OR = 1.24, 95.0% CI = 1.01‒1.52) and BMI (OR = 1.05, 95.0% CI = 1.01‒1.10) were associated with prediabetes. The other anthropometrics and sociodemographic parameters were not associated with prediabetes. In multivariate analysis, BRI and BMI were not associated with prediabetes. All the tested anthropometric parameters, WHR (AUC = 0.51, cutoff = 0.80, sensitivity = 0.69, specificity = 0.44), BRI (AUC = 0.57, cutoff = 1.77, sensitivity = 0.77, specificity = 0.42), ABSI (AUC = 0.51, cutoff = 0.14, sensitivity = 0.77, specificity = 0.31), BMI (AUC = 0.55, cutoff = 18.30 kg/m2, sensitivity = 0.45, specificity = 0.67), HC (AUC = 0.54, cutoff = 75.75 cm, sensitivity = 0.73, specificity = 0.36), and WC (AUC = 0.55, cutoff = 66.63 cm, sensitivity = 0.49, specificity = 0.63), had poor reliability in detecting prediabetes in adolescents.

Conclusion: This study demonstrated a lack of reliability of anthropometric parameters in predicting prediabetes among adolescents in eastern Sudan. Further extensive research is recommended in various regions of Sudan.

导言:全球青少年糖尿病前期和糖尿病发病率的增加,提出了通过人体测量参数早期预测这种代谢紊乱的问题,尤其是在苏丹等资源有限的地区。然而,这些人体测量预测指标的可靠性尚无定论。本研究旨在探讨人体测量指标(包括体重指数(BMI)、臀围(HC)、腰围(WC)、腰臀比(WHR)、体圆指数(BRI)和体形指数(ABSI))与苏丹东部青少年糖尿病前期之间的关联:这项基于社区的横断面研究在苏丹东部加达里夫市的青少年中进行。调查问卷用于收集社会人口信息。按照标准程序进行了人体测量和糖化血红蛋白(HbA1c)检测。生成了接收者工作特征曲线(ROC)。进行了多变量二元回归分析:在 401 名青少年中,186 名(46.4%)为女性,215 名(53.6%)为男性。年龄中位数(IQR)为 14.1(12.1-16.3)岁。BMI、WC、HC、WHR、BRI、ABSI 和 HbA1c 水平之间没有相关性。95名青少年(23.7%)被确诊为糖尿病前期,10名青少年(2.5%)被确诊为糖尿病。在单变量分析中,BRI(OR = 1.24,95.0% CI = 1.01-1.52)和体重指数(OR = 1.05,95.0% CI = 1.01-1.10)与糖尿病前期相关。其他人体测量和社会人口参数与糖尿病前期无关。在多变量分析中,BRI 和 BMI 与糖尿病前期无关。所有测试的人体测量参数,WHR(AUC = 0.51,临界值 = 0.80,灵敏度 = 0.69,特异性 = 0.44)、BRI(AUC = 0.57,临界值 = 1.77,灵敏度 = 0.77,特异性 = 0.42)、ABSI(AUC = 0.51,临界值 = 0.14,灵敏度 = 0.77,特异性 = 0.31)、BMI(AUC = 0.55,临界值 = 18.30 kg/m2,灵敏度 = 0.45,特异性 = 0.67)、HC(AUC = 0.54,临界值 = 75.75 cm,灵敏度 = 0.73,特异性 = 0.36)和 WC(AUC = 0.55,临界值 = 66.63 cm,灵敏度 = 0.49,特异性 = 0.63)在检测青少年糖尿病前期方面可靠性较差:这项研究表明,人体测量参数在预测苏丹东部青少年糖尿病前期方面缺乏可靠性。建议在苏丹各地区开展进一步的广泛研究。
{"title":"Accuracy of anthropometric parameters in predicting prediabetes among adolescents in Eastern Sudan: a community-based cross-sectional study.","authors":"Ola A El-Gendy, Walaa M Alsafi, Khadijah A Al-Shafei, Ahmed A Hassan, Ishag Adam","doi":"10.1186/s12902-025-01890-8","DOIUrl":"10.1186/s12902-025-01890-8","url":null,"abstract":"<p><strong>Introduction: </strong>The global increase of prediabetes and diabetes in adolescents raises the issue of early prediction of this metabolic disorder via anthropometric parameters, especially in limited resources settings such as Sudan. However, the reliability of these anthropometric predictors is inconclusive. This study aimed to examine the association between anthropometric measures, including body mass index (BMI), hip circumference (HC), waist circumference (WC), waist-to-hip ratio (WHR), body roundness index (BRI), and a body shape index (ABSI), and prediabetes in adolescents in eastern Sudan.</p><p><strong>Methods: </strong>This community-based cross-sectional study was conducted among adolescents in Gadarif City, Eastern Sudan. A questionnaire was used to collect sociodemographic information. Anthropometric and glycated hemoglobin (HbA1c) were performed following the standard procedures. The Receiver Operating Characteristic (ROC) curve was generated. Multivariate binary regression analysis was performed.</p><p><strong>Results: </strong>Among the 401 adolescents, 186 (46.4%) were female, and 215 (53.6%) were male. The median (IQR) age was 14.1 (12.1-16.3) years. There was no correlation between BMI, WC, HC, WHR, BRI, ABSI, and HbA1c levels. Ninety-five (23.7%) adolescents were identified with prediabetes and 10 (2.5%) with diabetes. In univariate analysis, BRI (OR = 1.24, 95.0% CI = 1.01‒1.52) and BMI (OR = 1.05, 95.0% CI = 1.01‒1.10) were associated with prediabetes. The other anthropometrics and sociodemographic parameters were not associated with prediabetes. In multivariate analysis, BRI and BMI were not associated with prediabetes. All the tested anthropometric parameters, WHR (AUC = 0.51, cutoff = 0.80, sensitivity = 0.69, specificity = 0.44), BRI (AUC = 0.57, cutoff = 1.77, sensitivity = 0.77, specificity = 0.42), ABSI (AUC = 0.51, cutoff = 0.14, sensitivity = 0.77, specificity = 0.31), BMI (AUC = 0.55, cutoff = 18.30 kg/m<sup>2</sup>, sensitivity = 0.45, specificity = 0.67), HC (AUC = 0.54, cutoff = 75.75 cm, sensitivity = 0.73, specificity = 0.36), and WC (AUC = 0.55, cutoff = 66.63 cm, sensitivity = 0.49, specificity = 0.63), had poor reliability in detecting prediabetes in adolescents.</p><p><strong>Conclusion: </strong>This study demonstrated a lack of reliability of anthropometric parameters in predicting prediabetes among adolescents in eastern Sudan. Further extensive research is recommended in various regions of Sudan.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"58"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143536628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic immune-inflammation index to albumin (SII/ALB) ratio as a novel dual-dimensional powerful predictor for hip fractures in elderly females with diabetes: a postmenopausal longitudinal cohort study. 全身免疫炎症指数与白蛋白(SII/ALB)比值作为老年女性糖尿病患者髋部骨折的新型双维有力预测指标:绝经后纵向队列研究。
IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-28 DOI: 10.1186/s12902-025-01889-1
Jie Lu, Fenglian Wei, Jingxia Sun, Zhenwei Zhai, Jiangmei Pan, Shishan Huang, Haolun Wang, Qiu Wang, Wenxin Chu, Jinming Yu, Jianhao Huang, Xubin Wu, Wensheng Lu
<p><strong>Purpose: </strong>Hip fracture is the most dangerous and potentially lethal fracture, described as "the last fracture of life" in older adults. Previous studies have shown that excessive immunoinflammatory response and nutrient deficiency may be involved. Nevertheless, a predictor for hip fracture risk that combines a thorough evaluation of immunoinflammatory with malnutritional conditions in postmenopausal women with type 2 diabetes mellitus (T2DM) remains scarce. This study explored the relationship between the SII/ALB ratio (SAR) and fragility fracture risk in postmenopausal older adults with T2DM.</p><p><strong>Methods: </strong>Between January 2014 and January 2021, a total of 509 postmenopausal female participants with T2DM were recruited from the Medical Record Database of the People's Hospital of Guangxi Zhuang Autonomous Region. Finally, 363 participants with an age median of 69.00 (64.00-75.00), were eligible for inclusion in this analysis. According to the statistical tertiles of the SAR, all participants were split into three groups: low-level (≤ 98.24, n = 121), moderate-level (98.24-157.25, n = 121), and high-level (≥ 157.25, n = 121). The participants were followed up for seven years, with a median follow-up time of 45.9 months (1389 person-years). The relationships between the SAR and a real-world fragility fracture event and an individualized future 10-year probability of major osteoporotic fracture (MOF) and hip fracture (HF) calculated by the fracture risk assessment tool (FRAX) were evaluated through Spearman's partial correlation analysis, restricted cubic spline (RCS) model, Cox proportional hazards regression model, and Kaplan-Meier survival analysis. Furthermore, some indicators such as geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and SII were also calculated and compared to their diagnostic efficacy and the clinical application value through the receiver operating characteristic (ROC) curve analysis and the decision curve analysis (DCA), respectively.</p><p><strong>Results: </strong>Of the 363 participants, 69 suffered a real-world fragility fracture event (19%). Spearman's partial correlation analysis indicated that SAR was negatively related to femoral neck (FN) bone mineral density (BMD) (r = -0.108, P = 0.041) and total hip (TH) BMD (r = -0.118, P = 0.025), but not lumbar spine (LS) BMD (all Models P > 0.05); positively correlated with an individualized future 10-year probability of MOF (r = 0.136, P = 0.010) and HF (r = 0.139, P = 0.008) calculated by FRAX, especially in hip fracture risk. The RCS model demonstrated the relationship between the SAR and a fragility fracture endpoint event in a J-shaped dose-dependent manner (P for overall < 0.001, P for nonlinear = 0.866). Multivariate Cox regression analysis indicated that the SAR was positively associated with fragility fracture risk (P < 0.001). Kaplan-Meier survival analysis showed that patients with higher levels of SAR
{"title":"Systemic immune-inflammation index to albumin (SII/ALB) ratio as a novel dual-dimensional powerful predictor for hip fractures in elderly females with diabetes: a postmenopausal longitudinal cohort study.","authors":"Jie Lu, Fenglian Wei, Jingxia Sun, Zhenwei Zhai, Jiangmei Pan, Shishan Huang, Haolun Wang, Qiu Wang, Wenxin Chu, Jinming Yu, Jianhao Huang, Xubin Wu, Wensheng Lu","doi":"10.1186/s12902-025-01889-1","DOIUrl":"10.1186/s12902-025-01889-1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;Hip fracture is the most dangerous and potentially lethal fracture, described as \"the last fracture of life\" in older adults. Previous studies have shown that excessive immunoinflammatory response and nutrient deficiency may be involved. Nevertheless, a predictor for hip fracture risk that combines a thorough evaluation of immunoinflammatory with malnutritional conditions in postmenopausal women with type 2 diabetes mellitus (T2DM) remains scarce. This study explored the relationship between the SII/ALB ratio (SAR) and fragility fracture risk in postmenopausal older adults with T2DM.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Between January 2014 and January 2021, a total of 509 postmenopausal female participants with T2DM were recruited from the Medical Record Database of the People's Hospital of Guangxi Zhuang Autonomous Region. Finally, 363 participants with an age median of 69.00 (64.00-75.00), were eligible for inclusion in this analysis. According to the statistical tertiles of the SAR, all participants were split into three groups: low-level (≤ 98.24, n = 121), moderate-level (98.24-157.25, n = 121), and high-level (≥ 157.25, n = 121). The participants were followed up for seven years, with a median follow-up time of 45.9 months (1389 person-years). The relationships between the SAR and a real-world fragility fracture event and an individualized future 10-year probability of major osteoporotic fracture (MOF) and hip fracture (HF) calculated by the fracture risk assessment tool (FRAX) were evaluated through Spearman's partial correlation analysis, restricted cubic spline (RCS) model, Cox proportional hazards regression model, and Kaplan-Meier survival analysis. Furthermore, some indicators such as geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and SII were also calculated and compared to their diagnostic efficacy and the clinical application value through the receiver operating characteristic (ROC) curve analysis and the decision curve analysis (DCA), respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 363 participants, 69 suffered a real-world fragility fracture event (19%). Spearman's partial correlation analysis indicated that SAR was negatively related to femoral neck (FN) bone mineral density (BMD) (r = -0.108, P = 0.041) and total hip (TH) BMD (r = -0.118, P = 0.025), but not lumbar spine (LS) BMD (all Models P &gt; 0.05); positively correlated with an individualized future 10-year probability of MOF (r = 0.136, P = 0.010) and HF (r = 0.139, P = 0.008) calculated by FRAX, especially in hip fracture risk. The RCS model demonstrated the relationship between the SAR and a fragility fracture endpoint event in a J-shaped dose-dependent manner (P for overall &lt; 0.001, P for nonlinear = 0.866). Multivariate Cox regression analysis indicated that the SAR was positively associated with fragility fracture risk (P &lt; 0.001). Kaplan-Meier survival analysis showed that patients with higher levels of SAR ","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"57"},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143522343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Endocrine Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1